On June 21, 2021 the FDA approved the first oral blood thinning medication, Pradaxa (dabigatran etexilate) oral pellets, to treat children 3 months to less than 12 years old who have venous thromboembolism (a condition where blood clots form in the veins) directly after they have been treated with a blood thinner given by injection for at least five days. The only other approved blood thinning medication for children is given by injection.
In November 2021 the dose-reduced vaccine rollout in children 5-11 years began. [1]
Is this getting ahead of the expectation that children will develop blood clots to the COVID-19 vaccines, and they can be treated at home – the press say no because it is not approved in children and “There’s no evidence connecting the Pfizer vaccine to blood clots”!